Evidence map›Paper›PMID 40615437›Full record

ReviewCell death & disease2025

The role of cardiolipin in mitochondrial dynamics and quality control in neuronal ischemia/reperfusion injury.

Katlynn J Emaus, Garrett M Fogo, Joseph M Wider, Thomas H Sanderson

Abstract readReview
In one paragraph

Review in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. DPAGT1-Perspective as an Anticancer Drug Target.Molecules (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katlynn J EmausNeuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA.
Garrett M FogoNeuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA.
Joseph M WiderNeuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA.
Thomas H SandersonNeuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA. thsand@med.umich.edu.ORCID http://orcid.org/0000-0003-0112-8164

Funding

Non-invasive mitochondrial modulation therapy for ischemic strokeR01NS120322 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUETTEMANN, MAIK, SANDERSON, THOMAS HUDSON · 2021 to 2025
$2.3M
Mitochondrial Modulation Therapy After Brain TraumaR01NS142271 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Joseph Wider · 2025 to 2026
$1.2M
Exploring the mechanisms of dysfunctional mitochondrial quality control in cerebrovascular disease and the aging brainK00AG079793 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Garrett McGuire Fogo · 2024 to 2026
$192k
Evaluation of Mitochondrial Cardiolipin Modification in Neonatal Hypoxia/Ischemia EncephalopathyF31NS129326 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI EMAUS, KATLYNN JOY · 2023 to 2025
$101k
Exploring the mechanisms of dysfunctional mitochondrial quality control in cerebrovascular disease and the aging brainF99AG079793 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FOGO, GARRETT MCGUIRE · 2022 to 2024
$60k
NIA NIH HHS F99 AG079793NIA NIH HHS K00 AG079793NINDS NIH HHS F31 NS129326NINDS NIH HHS R01 NS120322NINDS NIH HHS R01 NS142271U.S. Department of Defense (United States Department of Defense) W81XWH2211034U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 1F31NS129326-01A1U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 5R01NS120322-04U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) 1F99AG079793-01
6 · The paper itself

Abstract

Stroke and cardiac arrest claim the lives of millions worldwide each year emphasizing the importance of understanding this injury cascade. These pathologies present as a 'two hit' injury termed ischemia/reperfusion (I/R) injury. The primary injury is the initial disruption of blood flow and ischemic state while the secondary injury, paradoxically, being the return of blood flow and oxygen availability. The injury caused by reperfusion presents a viable window for therapeutic intervention, stressing the importance of understanding this injury pathology. Constantly undergoing fission and fusion, mitochondria are dynamic organelles that play a vital role in maintaining cell health and are highly susceptible to I/R injury. Following I/R injury, disrupted mitochondrial dynamics and quality control ultimately lead to a dysfunctional mitochondrial network, energy depletion and eventually cell death. While mitochondrial dynamics and quality control have been studied extensively in the realm of I/R injuries, the role of mitochondrial lipids is emerging as an important component of injury progression. The inner mitochondrial membrane lipid, cardiolipin has been demonstrated to play an integral role in maintaining mitochondrial quality control, dynamics and energy production. In response to oxidative stress, cardiolipin has been shown to interact with several important proteins involved in mitochondrial dynamics while also contributing to integral signaling cascades. This review will highlight the role of cardiolipin in mitochondrial dynamics and quality control in response to neuronal I/R injury.

Indexed as

CardiolipinsMitochondriaMitochondrial DynamicsNeuronsReperfusion InjuryAnimalsHumansCardiolipins

Identifiers

PMID40615437
PMCPMC12227610

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.